Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 56, Issue 12
Volume 56, Issue 12
15 June 2013
ISSN 1058-4838
EISSN 1537-6591

Volume 56, Issue 12, 15 June 2013

NEWS

Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1–2, https://doi.org/10.1093/cid/cit242

IN THE LITERATURE

Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 3–4, https://doi.org/10.1093/cid/cit241

IDSA PUBLIC POLICY

Helen W. Boucher and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1685–1694, https://doi.org/10.1093/cid/cit152

ARTICLES AND COMMENTARIES

Wai-Kay Seto and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1695–1703, https://doi.org/10.1093/cid/cit121

HLA-DP polymorphisms are associated with the chronicity of hepatitis B virus infection. Our current study demonstrated HLA-DP polymorphisms to be associated with hepatitis B surface antigen seroclearance, an important and favorable disease outcome of chronic hepatitis B.

Woottichai Khamduang and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1704–1712, https://doi.org/10.1093/cid/cit166

Among hepatitis B (HB) surface antigen–negative/human immunodeficiency virus–infected pregnant women in Thailand, 14% had isolated antibody to HB core antigen (anti-HBc); of whom 24% had occult HB virus (HBV) infection with low HBV DNA levels. None transmitted HBV to their infants.

Rana E. El Feghaly and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1713–1721, https://doi.org/10.1093/cid/cit147

Fecal inflammatory markers at diagnosis correlate with diarrhea persistence and treatment failure in Clostridium difficile infection, whereas C. difficile fecal bacterial burden does not. C. difficile bacterial concentration decreases similarly in patients treated with metronidazole and vancomycin.

Mary Beth Yacyshyn and Bruce Yacyshyn
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1722–1723, https://doi.org/10.1093/cid/cit151
Barbara D. Alexander and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1724–1732, https://doi.org/10.1093/cid/cit136

Echinocandin resistance is increasing among Candida glabrata while current consensus guidelines encourage the use of echinocandins as first-line therapy for this infection. The need for routine susceptibility testing of echinocandins for C. glabrata to guide therapeutic decision making is underscored.

Luis Ostrosky-Zeichner
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1733–1734, https://doi.org/10.1093/cid/cit140
Alex K. Owusu-Ofori and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1735–1741, https://doi.org/10.1093/cid/cit130

There is little evidence of transfusion-transmitted malaria (TTM) in malaria-endemic regions. A 2% incidence of TTM found in this study shows that TTM occurs infrequently among recipients of blood transfusion living in a malaria-endemic region.

Teske Schoffelen and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1742–1751, https://doi.org/10.1093/cid/cit129

Measurement of in vitro–specific interferon γ (IFN-γ) production can be used to diagnose preexisting immunity to Coxiella burnetii. In a cohort of 1525 individuals, an IFN-γ assay showed similar performance with and practical advantages over serology and skin testing.

Stephen R. Graves
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1752–1753, https://doi.org/10.1093/cid/cit132
Daniel J. Pallin and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1754–1762, https://doi.org/10.1093/cid/cit122

To date, no trial has assessed the effectiveness of antibiotics that target community-associated methicillin-resistant Staphylococcus aureus in the treatment of cellulitis. We treated 146 cellulitis patients with cephalexin plus either trimethoprim-sulfamethoxazole or placebo. Cure rates were similar in the 2 groups.

Henry F. Chambers
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1763–1764, https://doi.org/10.1093/cid/cit126

REVIEW ARTICLE

Joseph S. Solomkin and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1765–1773, https://doi.org/10.1093/cid/cit128

We analyzed the source control review process used in double-blind clinical trials of antibiotics in complicated intra-abdominal infections and provide recommendations for an independent, adjudicated source control review process applicable to future clinical trials.

BRIEF REPORT

H. Keipp Talbot and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1774–1777, https://doi.org/10.1093/cid/cit124

PHOTO QUIZ

Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page 1778, https://doi.org/10.1093/cid/cit131

INVITED ARTICLE

CLINICAL PRACTICE

Sebastiaan J. van Hal and Vance G. Fowler
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1779–1788, https://doi.org/10.1093/cid/cit178

The role of vancomycin has been challenged by the availability of alternative antibiotics, increased reports of vancomycin failure, and uncertainties in dosing. This manuscript considers the optimal treatment of methicillin-resistant Staphylococcus aureus infections.

HIV/AIDS

Neeraj Sood and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1789–1796, https://doi.org/10.1093/cid/cit158

The authors used a mathematical model to simulate the use of the test-and-treat policy for control of human immunodeficiency virus/AIDS in Los Angeles County. They found the significant epidemiologic benefits predicted by the model are counterbalanced by substantial increases in multidrug resistance.

Anupam B. Jena
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1797–1799, https://doi.org/10.1093/cid/cit159
The Antiretroviral Therapy Cohort Collaboration (ART-CC) and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1800–1809, https://doi.org/10.1093/cid/cit111

In 55 602 human immunodeficiency virus–positive patients from Canada, Europe, and the United States, the lower mortality found in migrants—largely due to non-AIDS causes—suggests “healthy migrant” effects, whereas the higher mortality of First Nations people and African Americans in North America suggests social inequality gaps.

Kimberly Y. Smith
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1810–1811, https://doi.org/10.1093/cid/cit116
Hiroyuki Gatanaga and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1812–1819, https://doi.org/10.1093/cid/cit145

Serological analysis of stocked serum samples showed lower incidence of hepatitis B virus (HBV) infection in non-HBV-vaccinated human immunodeficiency virus–infected men who have sex with men on lamivudine- or tenofovir disoproxil fumarate–based antiretroviral therapy.

Enju Liu and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1820–1828, https://doi.org/10.1093/cid/cit120

In human immunodeficiency virus–infected Tanzanian adults, lipid abnormalities were improved temporarily then worsened gradually over a 3-year follow-up following antiretroviral therapy initiation, with more unfavorable changes in patients on stavudine- and efavirenz-based regimens compared to zidovudine- and nevirapine-based regimens, respectively.

Jodie Dionne-Odom and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1829–1837, https://doi.org/10.1093/cid/cit146

In 2 large human immunodeficiency virus (HIV)–discordant couple cohorts in Africa, time to treatment response after penicillin therapy for a positive rapid plasma reagin test result was similar irrespective of HIV status. Despite effective therapy, serofast state and syphilis reinfection were common.

ANSWER TO THE PHOTO QUIZ

Shang-Yi Lin and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1838–1839, https://doi.org/10.1093/cid/cit135

CORRESPONDENCE

Chao Zhuo and Nan-Shan Zhong
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1840–1841, https://doi.org/10.1093/cid/cit149
Glen T. Hansen and Rebecca Zadroga
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1840–1841, https://doi.org/10.1093/cid/cit150
Mark J. DiNubile
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1841–1842, https://doi.org/10.1093/cid/cit148
R. Krause and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1842–1843, https://doi.org/10.1093/cid/cit115
Jaime Lora-Tamayo and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1843–1844, https://doi.org/10.1093/cid/cit119
Imad M. Tleyjeh and Larry M. Baddour
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1844–1845, https://doi.org/10.1093/cid/cit097
Bruno Baršić and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page 1845, https://doi.org/10.1093/cid/cit101
A. Sarah Walker and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1845–1846, https://doi.org/10.1093/cid/cit098
Seth T. Walk and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1846–1847, https://doi.org/10.1093/cid/cit099

BOOK REVIEWS

Catherine Diamond
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1848–1849, https://doi.org/10.1093/cid/cit163
David van Duin
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1848–1849, https://doi.org/10.1093/cid/cit141
Jason B. Harris
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1849–1850, https://doi.org/10.1093/cid/cit138

ERRATUM

Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page 1851, https://doi.org/10.1093/cid/cit215

ELECTRONIC ARTICLE

Joanna Regan and others
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages e105–107, https://doi.org/10.1093/cid/cit177

Ehrlichiosis is a tick-borne disease that ranges in severity from asymptomatic infection to fatal sepsis. A case of Ehrlichia ewingii infection likely transmitted by transfusion of leukoreduced platelets is described and public health implications are discussed.

COVER/STANDING MATERIAL

Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1057
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1080
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1103
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1126
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1149
Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Page NP, https://doi.org/10.1093/cid/cis1172
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close